返回
Know your target, know your molecule
DOI:10.1038/nchembio.1813.png)
摘要
En 中文
The pharmaceutical industry continues to experience significant attrition of drug candidates during phase 2 proof-of-concept clinical studies. We describe some questions about the characteristics of protein targets and small-molecule drugs that may be important to consider in drug-discovery projects and could improve prospects for future clinical success.
Keyword:
INHIBITORS
SELECTIVITY
DISCOVERY
BIOLOGY
GROWTH
POTENT
PROBES
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
13.7
论文数:
4.8K
被引数:
3.3W
机构
引用论文
ATP-Mediated Kinome Selectivity: The Missing Link in Understanding the Contribution of Individual JAK Kinase Isoforms to Cellular Signaling
ACS CHEMICAL BIOLOGY
IF3.8
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
DRUG DISCOVERY TODAY
IF7.5
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
NATURE CHEMICAL BIOLOGY
IF13.7

